RESUMEN
Late preterm infants (LPIs) represent a significant percentage of all neonates (6-8%), but there are limited published data on their postnatal management. Our aim was to compare the frequency of neonatal intensive care unit (NICU) admission and the breastfeeding rate of LPIs born at 35+0-36+6 weeks of gestation who were cared for by initial rooming in strategy rather than directly admitted to the special care unit (SCU) and, eventually, to the NICU. We carried out a retrospective study in the perinatal centers of Careggi University Hospital (CUH) and San Giovanni di Dio Hospital in Florence, Italy, where the first and second strategies were applied, respectively. Main outcomes were LPIs admission rate at SCU/NICU and breastfeeding rate at discharge. We studied 190 LPIs born at SGDH and 240 born at CUH. The admission rate in SCU (81 vs. 43%; P < 0.001) and NICU (20 vs. 10%; P = 0.008) was higher in SGDH than in CUH, as was the exclusive breastfeeding rate (36 vs. 22%; P < 0.001). However, infants who were assisted in rooming-in at CUH and infants with similar clinical characteristics at SGDH had similar mixed (60 vs. 69%) and exclusive (35 vs. 31%) breastfeeding rates. Conclusion: Postnatal assistance of LPIs in rooming-in, eventually followed by admission in SCU/NICU based on their clinical conditions, allowed to safely halve their hospitalization. The assistance of infants in rooming-in did not negatively affect their breastfeeding rate. These results support the possibility of assisting LPIs in rooming-in. What is Known: ⢠Late preterm infants represent a significant percentage of all neonates. ⢠Early rooming-in and breastfeeding is recommended for late preterm infants. What is New: ⢠Postnatal assistance of late preterm infants in rooming-in, followed when necessary by admission in neonatal units based on clinical conditions, allowed to safely avoid about half the number of hospitalizations in comparison with direct admission in neonatal units. ⢠This strategy did not affect breastfeeding rate. Infants who were admitted to SCU/NICU after initial rooming-in had worst breastfeeding rate.
Asunto(s)
Recien Nacido Prematuro , Unidades de Cuidado Intensivo Neonatal , Lactancia Materna , Femenino , Hospitalización , Humanos , Lactante , Recién Nacido , Embarazo , Estudios RetrospectivosRESUMEN
The leading route of Chagas disease transmission in nonendemic countries is congenital. However, policies concerning screening, prevention, and management of congenital Chagas disease are rare in these settings. Since 2012, serological screening for Chagas disease should be provided for pregnant women at risk in Tuscany, Italy according to a Regional resolution. Due to difficulties in the implementation, in November 2019, a checklist aimed at identifying pregnant women at risk for Chagas disease was introduced in digital clinical records at Careggi University Hospital, Florence, Italy. In order to evaluate the effectiveness of the "Chagas checklist", data about the number of deliveries by women at risk and their screening coverage between 2012 and June 2022 were collected. Out of 1348 deliveries by women at risk, 626 (47%) Trypanosoma cruzi serology tests were performed during the study period. The annual screening coverage increased from an average of 40.3% between 2012 and 2019 to 75.7% between 2020 and June 2022, underlining the big impact of the checklist. Four Chagas disease serological tests out of 626 (0.6%) resulted positive, corresponding to 2 affected women. No cases of congenital transmission occurred. The study showed that a simple digital tool led to a tangible improvement in the coverage of the screening program; its application in a setting where digital charts are available will contribute to the control and elimination of congenital Chagas disease.
RESUMEN
OBJECTIVES: To compare the endocrine effects of dopamine and dobutamine in hypotensive very low birthweight (VLBW) infants. DESIGN: Non-blinded randomised prospective trial. SETTING: Level III neonatal intensive care unit. PATIENTS: 35 hypotensive VLBW infants who did not respond to volume loading, assigned to receive dopamine or dobutamine. MEASUREMENTS: Haemodynamic variables and serum levels of thyroid stimulating hormone (TSH), total thyroxine (T(4)), prolactin (PRL) and growth hormone were assessed during the first 72 h of treatment and the first 72 h after stopping treatment. RESULTS: Demographic and clinical data did not significantly differ between the two groups. Necessary cumulative and mean drug doses and maximum infusion required to normalise blood pressure were significantly higher in the dobutamine than in the dopamine group (p<0.01). Suppression of TSH, T(4) and PRL was observed in dopamine-treated newborns from 12 h of treatment onwards, whereas levels of growth hormone reduced significantly only at 12 h and 36 h of treatment (p<0.01). TSH, T(4) and PRL rebound was observed from the first day onwards after stopping dopamine. Dobutamine administration did not alter the profile of any of the hormones and no rebound was observed after stopping treatment. CONCLUSION: Dopamine and dobutamine both increase the systemic blood pressure, though dopamine is more effective. Dopamine reduces serum levels of TSH, T(4) and PRL in VLBW infants but such suppression is quickly reversed after treatment is stopped. Further research is required to assess if short-term iatrogenic pituitary suppression has longer-term consequences.
Asunto(s)
Cardiotónicos/uso terapéutico , Dobutamina/uso terapéutico , Dopamina/uso terapéutico , Hipotensión/tratamiento farmacológico , Recién Nacido de muy Bajo Peso , Presión Sanguínea/efectos de los fármacos , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Hormona de Crecimiento Humana/sangre , Humanos , Recién Nacido , Cuidado Intensivo Neonatal/métodos , Masculino , Prolactina/sangre , Estudios Prospectivos , Tirotropina/sangre , Tiroxina/sangre , Resultado del TratamientoRESUMEN
OBJECTIVE: Catheter-related bloodstream infections (CRBSIs) are one of the main morbidities in critically ill neonates. The objective of the present study was to assess the efficacy of a fusidic acid-heparin lock in the prevention of CRBSIs. DESIGN: A preliminary retrospective study showed that staphylococcal infections were largely prevalent. We planned a prospective, randomized trial to ascertain whether fusidic acid and heparin lock of central venous catheters would reduce the incidence of CRBSIs. SETTING: Level III neonatal intensive care unit. PATIENTS: One hundred three neonates were enrolled and randomly assigned to a treatment group (n = 50) or control group (n = 53). INTERVENTIONS: Fusidic acid (4 mg/mL) and heparin (10 IU/mL) lock in the treatment group. MEASUREMENTS AND MAIN RESULTS: The treatment group showed significantly lower incidence of CRBSIs (6.6 vs. 24.9 per 1000 catheter days; p < .01; relative risk 0.28; 95% confidence interval 0.13-0.60). No staphylococcal infections occurred in the treatment group, while in the control group Staphylococcus remained the main agent of CRBSI. Cost analysis comparing the present study and for the treatment of CRBSIs proved that antibiotic lock is financially favorable. CONCLUSIONS: Fusidic acid-heparin lock solution reduced the incidence of CRBSIs in our neonatal intensive care unit. However, we recommend basing antibiotic lock on local CRBSI epidemiology. With regard to fusidic acid, further and broader studies could be useful to confirm our results.
Asunto(s)
Antibacterianos/uso terapéutico , Anticoagulantes/uso terapéutico , Bacteriemia/prevención & control , Catéteres de Permanencia/microbiología , Cuidados Críticos/métodos , Infección Hospitalaria/prevención & control , Ácido Fusídico/uso terapéutico , Heparina/uso terapéutico , Unidades de Cuidado Intensivo Neonatal , Antibacterianos/administración & dosificación , Anticoagulantes/administración & dosificación , Cateterismo Venoso Central/efectos adversos , Infección Hospitalaria/microbiología , Femenino , Ácido Fusídico/administración & dosificación , Heparina/administración & dosificación , Humanos , Recién Nacido , Masculino , Estudios Prospectivos , Estudios Retrospectivos , Infecciones Estafilocócicas/prevención & control , Resultado del TratamientoRESUMEN
The aim of the present study was to evaluate if high-frequency oscillatory ventilation (HFOV) might reduce lung inflammation in preterm infants with infant respiratory distress syndrome (RDS) in comparison with the early application of another potentially lung-protective ventilation strategy, such as pressure support ventilation plus volume guarantee (PSV + VG). Infants at less than 30 weeks of gestation with RDS were enrolled consecutively in the study if they required mechanical ventilation, and were randomly allocated to receive HFOV or PSV + VG. Bronchial aspirate samples for the measurement of interleukin (IL)-1beta, IL-8, and IL-10 were obtained before surfactant treatment (T1), after 6-18 hr of ventilation (T2), after 24-48 hr of ventilation (T3), and before extubation (T4). Thirteen patients were enrolled in the HFOV group, and 12 in the PSV + VG group. The mean values of IL-1beta, IL-8, and IL-10 at T4 were lower in the HFOV group than in the PSV + VG group. The present study demonstrates that early treatment with HFOV is associated with a reduction of lung inflammation in comparison with PSV + VG in preterm infants with RDS.
Asunto(s)
Displasia Broncopulmonar/terapia , Citocinas/análisis , Ventilación de Alta Frecuencia/métodos , Recien Nacido Prematuro , Respiración con Presión Positiva/métodos , Síndrome de Dificultad Respiratoria del Recién Nacido/terapia , Líquido del Lavado Bronquioalveolar/química , Displasia Broncopulmonar/diagnóstico , Displasia Broncopulmonar/mortalidad , Femenino , Estudios de Seguimiento , Ventilación de Alta Frecuencia/efectos adversos , Humanos , Recién Nacido , Inflamación/fisiopatología , Inflamación/prevención & control , Mediadores de Inflamación/análisis , Masculino , Probabilidad , Estudios Prospectivos , Síndrome de Dificultad Respiratoria del Recién Nacido/diagnóstico , Síndrome de Dificultad Respiratoria del Recién Nacido/mortalidad , Pruebas de Función Respiratoria , Medición de Riesgo , Índice de Severidad de la Enfermedad , Tasa de Supervivencia , Resultado del TratamientoRESUMEN
OBJECTIVE: To describe the possibility that dopamine infusion can prevent early diagnosis of congenital hypothyroidism. DESIGN: Case report. SETTING: Medical neonatal intensive care unit of a tertiary academic medical center. PATIENTS: We report four preterm newborns affected by transient primary congenital hypothyroidism who showed low serum thyroxine and normal thyroid-stimulating hormone concentrations on primary screening performed during treatment with dopamine. INTERVENTIONS: Thyroid reevaluation screening after dopamine discontinuation. MEASUREMENTS AND MAIN RESULTS: Thyroid reevaluation showed elevated thyroid-stimulating hormone levels. CONCLUSION: We emphasize that dopamine capacity to suppress thyroid-stimulating hormone could prevent early diagnosis of congenital hypothyroidism. We suggest all newborns to be tested simultaneously for thyroid-stimulating hormone and thyroxine values at primary screening. A reevaluation of thyroid hormones after dopamine discontinuation is advisable in patients treated with dopamine.
Asunto(s)
Hipotiroidismo Congénito/inducido químicamente , Dopamina/efectos adversos , Dopamina/administración & dosificación , Femenino , Humanos , Recién Nacido , Recien Nacido Prematuro , Infusiones Intravenosas , Masculino , Tamizaje Neonatal , Tirotropina/efectos de los fármacosRESUMEN
OBJECTIVE: To determine the incidence of cardiac tamponade related to peripherally inserted central catheters in newborns weighing less than 1,500 g during the past 8 years and to provide guidelines in order to avoid death due to this complication. DESIGN: Retrospective case review. SETTING: Tertiary level neonatal intensive care unit. PATIENTS AND PARTICIPANTS: Retrospective study of a total of 280 peripherally inserted central catheters positioned in 258 preterm newborns. MEASUREMENTS AND RESULTS: Five cardiac tamponades were observed, giving an incidence of 1.8%. Data from our cases included clinical presentation and outcome, biochemical evaluation of pericardial fluid, days until diagnosis, central catheters characteristics, insertion site and tip placement site. INTERVENTION: Two of the infants did not respond to resuscitation measures including cardiac massage and the administration of epinephrine. Post-mortem examination revealed the intrapericardial accumulation of protein and lipid alimentation solution. The other three patients were successfully resuscitated by timely pericardiocentesis. All five infants had routinely performed serial radiographs and cardiac color Doppler ultrasonography that showed correct catheter tip placement. CONCLUSIONS: The incidence of cardiac tamponade could be reduced by following specific guidelines. The possibility of tamponade must be kept in mind during the resuscitation of any preterm infant with a peripherally inserted central catheter in place who develops symptoms of shock or sudden bradycardia. Our experience shows that even preterm infants with cardiac tamponade can be successfully resuscitated by timely pericardiocentesis in most cases.
Asunto(s)
Taponamiento Cardíaco/etiología , Cateterismo Venoso Central/efectos adversos , Taponamiento Cardíaco/mortalidad , Taponamiento Cardíaco/terapia , Cateterismo Venoso Central/instrumentación , Diseño de Equipo , Femenino , Humanos , Recién Nacido , Recien Nacido Prematuro , Unidades de Cuidado Intensivo Neonatal , Masculino , Pericardiocentesis , Estudios RetrospectivosAsunto(s)
Antifúngicos/uso terapéutico , Fluconazol/uso terapéutico , Enfermedades del Prematuro/prevención & control , Micosis/prevención & control , Candida/aislamiento & purificación , Errores Diagnósticos , Humanos , Recién Nacido , Recien Nacido Prematuro , Micosis/diagnóstico , Infecciones Urinarias/diagnóstico , Infecciones Urinarias/microbiología , Orina/microbiologíaRESUMEN
The aim of the No Pain in Labour (NoPiL) study was to evaluate the stress and clinical outcome of infants vaginally born without maternal analgesia and after maternal epidural or systemic analgesia. We studied 120 healthy term infants, 41 in the no analgesia group, 38 in the epidural analgesia group, and 41 in the systemic analgesia group. Cortisol, beta-endorphin, oxidative stress markers (ie: total hydroperoxide (TH) and advanced oxidation protein products (AOPP)), interleukin-1beta (IL-1beta), and interleukin-8 (IL-8) cytokines were measured in arterial cord blood samples. Infants in the 3 groups had similar Apgar score, cord blood pH and occurrence of hypoglycaemia, hyperbilirubinemia, and respiratory depression. Cortisol and endorphin plasma levels did not differ in the groups, nor did TH and AOPP values. IL-1beta and IL-8 cytokine were higher in infants born after maternal epidural analgesia than in other groups. Short-term outcome and stress were similar in infants vaginally born without maternal analgesia and after epidural and systemic analgesia. The possible implications of the highest interleukin levels in the epidural analgesia group deserve further study.
Asunto(s)
Analgesia Epidural , Analgésicos/administración & dosificación , Exposición Materna , Femenino , Humanos , Hidrocortisona/sangre , Recién Nacido , Interleucina-1/sangre , Interleucina-8/sangre , Estrés Oxidativo , Embarazo , betaendorfina/sangreRESUMEN
OBJECTIVES: To compare the ultrasound examination with pH-metry in order to evaluate the diagnostic accuracy of sonography for diagnosis of gastro-oesophageal reflux (GOR) in preterm infants. METHODS: A prospective study was conducted on 31 premature infants <34 weeks with clinically diagnosed GOR. First, they underwent 24-hour pH-monitoring; successively, the sonographic assessment was performed within 12 h after pH-monitoring. The two operators who performed the pH-monitoring and sonography respectively, were unaware of each other's results. RESULTS: Twenty-one patients (67.7%) had significant GOR with a reflux index >5 (GOR group). The median (range) reflux index in this group was 9.19% (6.04-20.1). Ten newborns (32.3%) did not have significant GOR with a reflux index <5. Sonography was positive for GOR in 8 patients (25.8%); all 8 infants with sonographic diagnosis of GOR had a reflux index >5. Therefore, sonographic diagnosis did not produce false positives. Sonography was negative in 23 newborns (74.2%); 13 of these were positive to pH-monitoring and may therefore be considered as false negatives. Respect to continuous 24-hour pH-monitoring, sonography showed a specificity of 100% but a very low sensitivity of 38% with a positive prediction value of 100% and a negative prediction value of 43%. CONCLUSIONS: Sonography should not replace 24-hour pH monitoring for detecting GOR in preterm infants. However, sonography has a very high specificity and a positive predictive value of 100%. When clinicians suspect GOR in preterm infants, it could be useful for selection of cases to refer for pH-metry.
Asunto(s)
Monitorización del pH Esofágico , Monitoreo Fetal , Reflujo Gastroesofágico/diagnóstico por imagen , Recien Nacido Prematuro , Ultrasonografía Prenatal , Femenino , Reflujo Gastroesofágico/fisiopatología , Humanos , Recién Nacido , Masculino , Valor Predictivo de las Pruebas , Estudios Prospectivos , Reproducibilidad de los ResultadosRESUMEN
BACKGROUND: Doxapram is a respiratory stimulant widely used for the treatment of idiopathic apnea of prematurity, although it has been demonstrated that it can induce a transient decrease of cerebral blood flow and that isolated mental delay in infants weighing <1,250 g is associated with the total dosage and duration of doxapram therapy. OBJECTIVES: To evaluate the effects of doxapram on cerebral hemodynamics in preterm infants using cerebral Doppler ultrasonography and near-infrared spectroscopy. METHODS: Preterm infants who required treatment with doxapram for apnea of prematurity unresponsive to caffeine were treated with doxapram at an hourly dose of 0.5 mg x kg(-1).h(-1), followed by 1.5 and 2.5 mg x kg(-1).h(-1). RESULTS: 20 preterm infants were studied. Doxapram induced a significant decrease of oxygenated hemoglobin (O(2)Hb) and cerebral intravascular oxygenation (HbD = O(2)Hb - HHb) and an increase of HHb and CtOx concentrations, while cerebral blood volume and cerebral blood flow velocity did not change. CONCLUSIONS: Doxapram infusion induces the increase of cerebral oxygen consumption and requirement and the contemporary decrease of oxygen delivery probably mediated by a decrease of cerebral blood flow. Caution must be recommended in prescribing this drug for apnea of prematurity.
Asunto(s)
Encéfalo/irrigación sanguínea , Doxapram/efectos adversos , Enfermedades del Prematuro/tratamiento farmacológico , Recien Nacido Prematuro , Fármacos del Sistema Respiratorio/efectos adversos , Apnea/tratamiento farmacológico , Peso al Nacer , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Estudios de Casos y Controles , Doxapram/administración & dosificación , Edad Gestacional , Humanos , Recién Nacido , Oxígeno/sangre , Oxihemoglobinas/análisis , Estudios Prospectivos , Fármacos del Sistema Respiratorio/administración & dosificación , Estudios RetrospectivosRESUMEN
BACKGROUND: Previous studies demonstrated that dopamine infusion reduces plasma concentration of thyroxine (T4), thyroid stimulating hormone (TSH), prolactin (PRL), and growth hormone (GH) in adults, children, and infants. OBJECTIVES: The purpose of this prospective observational study was to evaluate the relationship between dopamine infusion and the dynamics of T4, TSH, PRL, and GH in preterm newborns weighing less than 1,500 g (very low birth weight infants, VLBW) admitted in a neonatal intensive care unit of a university hospital over a one year period. METHODS: A total of 97 preterm newborns were enrolled and divided into two groups: group B included hypotensive infants treated with plasma expanders and dopamine infusion; group A was the control group including newborns who were never treated with dopamine. The newborns were studied dynamically through blood samples taken every day till 10 days. Newborns of group B were studied during dopamine infusion and after its withdrawal. RESULTS: Among the VLBW newborns who were given dopamine, the four pituitary hormones had different dynamics: a reduction of T4, TSH, and PRL levels was noticed since the first day of treatment, and a rebound of their levels was evident since the first day after its interruption. On the contrary, the postprandial GH levels were roughly constant: GH plasma concentrations were in fact a little lower in newborns treated with dopamine, and a slight increase was observed after its withdrawal. However, observed differences were not statistically significant. CONCLUSIONS: The results suggest that dopamine infusion reduces T4, TSH, and PRL plasma levels in preterm VLBW infants and have no effect on postprandial GH rate. This hormonal suppression reverses rapidly after dopamine withdrawal. This observation suggests that the iatrogenic pituitary suppression probably cannot produce long-term injuries.
Asunto(s)
Dopamina/administración & dosificación , Dopamina/farmacología , Adenohipófisis/efectos de los fármacos , Adenohipófisis/fisiología , Femenino , Hormona del Crecimiento/sangre , Humanos , Recién Nacido , Recién Nacido de muy Bajo Peso , Masculino , Prolactina/sangre , Tirotropina/sangre , Tiroxina/sangre , Factores de TiempoRESUMEN
AIM: To test the hypothesis that inhaled nitric oxide therapy can decrease the incidence of bronchopulmonary dysplasia and death in preterm infants with severe respiratory distress syndrome; to evaluate the possible predictive factors for the response to inhaled nitric oxide therapy. METHODS: Preterm infants (less than 30 weeks' gestation) were randomized to receive during the first week of life inhaled nitric oxide, or nothing, if they presented severe respiratory distress syndrome. Then, the treated infants were classified as non responders and responders. RESULTS: Twenty infants were enrolled in the inhaled nitric oxide therapy group and 20 in the control group. Bronchopulmonary dysplasia and death were less frequent in the inhaled nitric oxide group than in the control group (50 vs. 90%, p=0.016). Moreover, nitric oxide treatment was found to decrease as independent factor the combined incidence of death and BPD (OR=0.111; 95% C.I. 0.02-0.610). A birth weight lower than 750 grams had a significant predictive value for the failure of responding to inhaled nitric oxide therapy (OR 12; 95% C.I. 1.3-13.3). CONCLUSION: Inhaled nitric oxide decreases the incidence of bronchopulmonary dysplasia and death in preterm infants with severe respiratory distress syndrome. Birth weight may influence the effectiveness of inhaled nitric oxide therapy in promoting oxygenation improvement in preterm infants.
Asunto(s)
Peso al Nacer , Broncodilatadores/uso terapéutico , Displasia Broncopulmonar/prevención & control , Óxido Nítrico/uso terapéutico , Síndrome de Dificultad Respiratoria del Recién Nacido/tratamiento farmacológico , Humanos , Recién Nacido , Recien Nacido Prematuro , Resultado del TratamientoRESUMEN
BACKGROUND: Placement of a feeding tube may be associated with various complications, including iatrogenic pharyngo-oesophageal perforation. AIM: To determine the incidence of pharyngo-oesophageal perforation secondary to the use of polyvinyl feeding tubes in newborns weighing less than 1500 g, we conducted a retrospective study over a 3(1/2)-y period. METHODS: All the hospital files of the 371 very-low-birthweight newborns admitted were retrospectively reviewed. RESULTS: Three iatrogenic pharyngo-oesophageal perforations were observed, giving an incidence of 1:124 preterm infants. This incidence reaches values of 1:25 newborns weighing less than 750 g. Data from our cases included clinical presentation and outcome, radiological evaluation, and type of feeding tube. One infant died of sepsis, and the clinical course was compatible with mediastinitis. The other two infants were treated successfully with conservative non-surgical management. CONCLUSION: Pharyngo-oesophageal perforation in our experience exclusively involved preterm infants weighing less than 750 g after traumatic placement of a polyvinyl feeding tube. The use of a silastic feeding tube with a really soft end instead of polyvinyl catheters could probably avoid iatrogenic oesophageal perforation.
Asunto(s)
Perforación del Esófago/etiología , Enfermedad Iatrogénica , Recién Nacido de muy Bajo Peso , Intubación Intratraqueal/efectos adversos , Faringe/lesiones , Nutrición Enteral , Resultado Fatal , Femenino , Humanos , Recién Nacido , Recien Nacido Prematuro , Masculino , PolivinilosRESUMEN
Linear branching echogenicities in the thalamus or basal ganglia have been reported in infants with several genetic and nongenetic disorders. In this article, we report 2 cases of newborns with a neurosonographic diagnosis of thalamic/basal ganglia vasculopathy and karyotype analysis showing pericentric inversion of chromosome 2. To our knowledge, there has been no previous mention of an association between these entities.
Asunto(s)
Ganglios Basales/irrigación sanguínea , Ganglios Basales/diagnóstico por imagen , Inversión Cromosómica/genética , Cromosomas Humanos Par 2 , Malformaciones Arteriovenosas Intracraneales/diagnóstico por imagen , Ganglios Basales/anomalías , Aberraciones Cromosómicas , Estudios de Seguimiento , Humanos , Recién Nacido , Malformaciones Arteriovenosas Intracraneales/genética , Masculino , Tálamo/anomalías , Tálamo/irrigación sanguínea , Tálamo/diagnóstico por imagen , Ultrasonografía Doppler TranscranealRESUMEN
OBJECTIVE: Ibuprofen enhances cerebral blood flow autoregulation and was shown to protect neurologic functions after oxidative stresses in an animal model. For these reasons, we hypothesized that the prophylactic use of ibuprofen would reduce the occurrence of intraventricular hemorrhage (IVH) and its worsening toward grades 2 to 4 among preterm infants. To confirm this hypothesis, we planned the present prospective study. METHODS: This was a double-blind, randomized, controlled trial in which preterm infants with gestational ages of <28 weeks received ibuprofen or placebo within the first 6 hours of life. The infants were assigned randomly, at 7 neonatal care units, to receive ibuprofen (10 mg/kg, followed by 5 mg/kg after 24 and 48 hours) or placebo. Serial echoencephalography was performed 24 and 48 hours after the initial cerebral ultrasound study, on postnatal days 7, 15, and 30, and at 40 weeks' postconceptional age. Grade 1 IVH or no IVH was considered a successful outcome, whereas grade 2 to 4 IVH represented failure. The rates of ductal closure, side effects, and complications were recorded. RESULTS: We studied 155 infants. Grade 2 to 4 IVH developed for 16% of the ibuprofen-treated infants and 13% of the infants in the placebo group. The occurrence of patent ductus arteriosus was less frequent only on day 3 of life in the ibuprofen group. There were no significant differences with respect to other complications or adverse effects. CONCLUSIONS: Our study demonstrated that prophylactic ibuprofen is ineffective in preventing grade 2 to 4 IVH and that its use for this indication cannot be recommended.
Asunto(s)
Hemorragia Cerebral/prevención & control , Ibuprofeno/uso terapéutico , Enfermedades del Prematuro/prevención & control , Cuidado Intensivo Neonatal/métodos , Fármacos Neuroprotectores/uso terapéutico , Hemorragia Cerebral/diagnóstico por imagen , Hemorragia Cerebral/epidemiología , Ventrículos Cerebrales , Circulación Cerebrovascular/efectos de los fármacos , Método Doble Ciego , Conducto Arterioso Permeable/diagnóstico por imagen , Conducto Arterioso Permeable/tratamiento farmacológico , Ecoencefalografía , Femenino , Edad Gestacional , Trastornos Hemorrágicos/inducido químicamente , Humanos , Ibuprofeno/administración & dosificación , Ibuprofeno/efectos adversos , Recién Nacido , Recien Nacido Prematuro , Enfermedades del Prematuro/diagnóstico por imagen , Enfermedades del Prematuro/tratamiento farmacológico , Enfermedades del Prematuro/epidemiología , Unidades de Cuidado Intensivo Neonatal/estadística & datos numéricos , Italia/epidemiología , Masculino , Fármacos Neuroprotectores/administración & dosificación , Fármacos Neuroprotectores/efectos adversos , Estudios Prospectivos , Índice de Severidad de la Enfermedad , Trombocitopenia/inducido químicamente , Resultado del TratamientoRESUMEN
In this paper, the magnetic flux density (MFD) distribution in a neonatal intensive care unit is described and MFD values inside a few open infant warming systems and incubators are reported. Typical measured values of the magnetic flux density at power frequency (50 Hz) in the "general environment" (the rooms of the unit) were lower than 0.2 microT, while higher MFD values were detected close to medical equipment and inside the open infant warming systems. In both cases, the magnetic flux density quickly decreases with increasing distance, so that measured values are reduced to "background" (i.e., general environment) levels 20-30 cm away from the sources. The total harmonic content over the 100-800 Hz frequency range was also evaluated. In the general environment, measured values in this band were negligible, while this was not the case close to medical equipment. Field levels inside the open and closed incubators depend on the position of the electronic control system, of the heating power generator and its winding conductor, and of the 220 V main plug. The magnetic flux density was also monitored for a prolonged period of time in a few types of open infant warming systems and incubators under standard intensive care unit operation with premature newborn present.